Diagnostic accuracy study
Why this level?
Specify the reference standard. Accuracy cannot be classified from diagnostic yield alone. NHMRC 2009 sourceDiagnostic accuracy needs its own hierarchy. The level depends on the reference standard, independence, blinding, clinical presentation and recruitment. A design title alone does not establish those features.
Where the NHMRC 2009 hierarchy names this design, it places it here:
| Research question | Level | When |
|---|---|---|
| Diagnostic accuracy | II | Consecutive patients with a defined clinical presentation undergo an independent blinded comparison against a valid reference standard. |
| Diagnostic accuracy | III-1 | Nonconsecutive patients with a defined clinical presentation undergo an independent blinded comparison against a valid reference standard. |
| Diagnostic accuracy | III-2 | The reference-standard comparison does not meet all criteria for Levels II or III-1. |
| Diagnostic accuracy | III-3 | Known cases and a separate healthy control group are assembled for the diagnostic comparison; the clinical spectrum may be unrepresentative. |
| Diagnostic accuracy | IV | Diagnostic yield is measured without a reference standard to confirm accuracy. |
What question does this help answer?
“How accurately does this test classify people as having or not having the target condition?”
When to use it
Use this design when evaluating a diagnostic test, screening tool, algorithm, imaging method, laboratory assay, or other classifier against a credible reference standard.
When not to use it
Do not frame a study as diagnostic accuracy when there is no meaningful target condition or reference standard, or when the main objective is prognosis rather than diagnosis.
How it works in plain language
Participants receive the index test and the reference-standard assessment. Results are compared to estimate measures such as sensitivity, specificity, predictive values, likelihood ratios, or discrimination. Threshold choice and disease prevalence affect interpretation.
What the study's flow looks like
Why Mallard may recommend it
Mallard may recommend this design when the research question asks whether a clinical test or algorithm correctly identifies a current disease or condition.
Key assumptions and design requirements
- The participant spectrum reflects the intended use population.
- The reference standard is appropriate.
- Index-test interpretation is blinded to reference-standard results when feasible, and vice versa.
- Verification is not selectively applied based on the index result.
- Thresholds are prespecified when confirmatory accuracy is the objective.
Intervals for sensitivity and specificity
Sensitivity is a proportion among the people with the condition and specificity a proportion among those without, so each is reported with an interval for a single proportion: a Wilson or Clopper-Pearson interval, not the simple normal approximation, which behaves badly when accuracy is close to 100 percent and can give an upper limit above it. The number of people with the condition, not the total enrolled, governs how precise sensitivity is, which is why a study with few cases can report a high sensitivity with a wide interval. Predictive values are single proportions too, but they hold only at the prevalence of the study sample.
What to watch out for
Case-control sampling of obvious diseased and healthy participants can exaggerate apparent accuracy. Predictive values depend on prevalence. Accuracy alone does not establish clinical utility.
Clinical example
Evaluate whether a new EHR-based screening score identifies current sepsis compared with an adjudicated clinical reference standard.
- STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (opens in a new tab) · EQUATOR Network
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration (opens in a new tab) · BMJ Open · doi 10.1136/bmjopen-2016-012799
- Two-sided confidence intervals for the single proportion: comparison of seven methods (opens in a new tab) · Stat Med · doi 10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e